Journal article
Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT.
Abstract
A 51-year-old man diagnosed with high-grade, high-volume metastatic castration-sensitive prostate adenocarcinoma received pelvic radiation, androgen deprivation therapy, and intravenous docetaxel. Serum prostate-specific antigen became undetectable following treatment. Within a year, his cancer progressed to castration-resistant disease, and he was treated with oral abiraterone acetate 1000 mg and prednisone 10 mg daily. Despite this, the serum …
Authors
Zukotynski KA; Jadvar H; Potvin K; Cho SY; Kim CK; Winquist E
Journal
Clinical Nuclear Medicine, Vol. 45, No. 9, pp. 727–729
Publisher
Wolters Kluwer
Publication Date
September 2020
DOI
10.1097/rlu.0000000000003109
ISSN
0363-9762